- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$27.8b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$182.65
7D
-6.5%
1Y
26.9%
BioNTech
Market Cap: US$21.0b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$85.68
7D
-4.0%
1Y
-9.8%
Illumina
Market Cap: US$19.0b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$117.67
7D
-5.4%
1Y
47.1%
Sam Chun Dang Pharm
Market Cap: ₩25.8t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩1,111,000.00
7D
22.5%
1Y
557.4%
Regencell Bioscience Holdings
Market Cap: US$12.6b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$25.67
7D
-6.2%
1Y
3,700.0%
Elanco Animal Health
Market Cap: US$12.2b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.13
7D
-3.5%
1Y
122.2%